Lubomir Bodnar
About
In The Last Decade
Lubomir Bodnar
86 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 461
- Oncology 455
- Pulmonary and Respiratory Medicine 315
- Cancer Research 229
- Pathology and Forensic Medicine 188
Countries citing papers authored by Lubomir Bodnar
This map shows the geographic impact of Lubomir Bodnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubomir Bodnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubomir Bodnar more than expected).
Fields of papers citing papers by Lubomir Bodnar
This network shows the impact of papers produced by Lubomir Bodnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubomir Bodnar. The network helps show where Lubomir Bodnar may publish in the future.
Co-authorship network of co-authors of Lubomir Bodnar
This figure shows the co-authorship network connecting the top 25 collaborators of Lubomir Bodnar. A scholar is included among the top collaborators of Lubomir Bodnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubomir Bodnar. Lubomir Bodnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 33 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 0 | |
| 13 | 2 | |
| 14 | Epidemiology of colorectal cancer | 1 |
| 15 | The role of hormone replacement therapy and the risk of development of ovarian cancer | 1 |
| 16 | Adiuvant therapy of colorectal cancer | 2 |
| 17 | Docetaxel and paclitaxel: comparison of their pharmacology and mechanisms of resistance | 1 |
| 18 | The role of macrophage colony-stimulating factor (M-CSF) in prognosis, diagnosis and in the treatment of epithelial ovarian cancer | 2 |
| 19 | Renal nephroprotection during chemotherapy with platinum compounds in cancer patients | 1 |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.